US Stock MarketDetailed Quotes

SNNAQ Sienna Biopharmaceuticals, Inc.

Watchlist
  • 0.000001
  • 0.0000000.00%
15min DelayClose Dec 11 16:00 ET
30.91Market Cap0.00P/E (TTM)

Sienna Biopharmaceuticals, Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2019
(Q2)Jun 30, 2019
(Q1)Mar 31, 2019
(FY)Dec 31, 2018
(Q4)Dec 31, 2018
(Q3)Sep 30, 2018
(Q2)Jun 30, 2018
(Q1)Mar 31, 2018
(FY)Dec 31, 2017
(Q4)Dec 31, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-12.30%-17.84M
46.56%-8.42M
11.66%-12.77M
-50.43%-61.69M
-10.78%-15.6M
-69.03%-15.89M
-36.64%-15.75M
-140.76%-14.46M
-132.90%-41.01M
-188.25%-14.08M
Net income from continuing operations
76.36%-3.97M
59.17%-8.26M
4.22%-16.38M
-45.36%-73.47M
-72.80%-19.34M
-2.46%-16.79M
-57.39%-20.24M
-69.22%-17.1M
-138.85%-50.55M
-35.00%-11.19M
Operating gains losses
--21K
--1K
--1K
-40.00%3K
--0
----
----
----
--5K
--0
Depreciation and amortization
-7.69%36K
-5.13%37K
0.00%39K
30.83%157K
0.00%40K
44.44%39K
44.44%39K
50.00%39K
79.10%120K
73.91%40K
Other non cash items
-7,627.48%-33.46M
134.47%151K
1,411.08%5.05M
-35.01%3.75M
258.30%4.29M
-112.17%-433K
-118.47%-438K
-86.93%334K
916.73%5.78M
-401.45%-2.71M
Change In working capital
-4,060.30%-8.28M
-131.16%-1.21M
-319.80%-3.02M
108.09%3.17M
-48.79%-1.9M
-107.48%-199K
411.19%3.89M
-1.08%1.37M
-39.28%1.52M
-154.54%-1.28M
-Change in prepaid assets
-1,996.69%-6.96M
123.96%92K
-24.31%383K
173.91%997K
286.27%1.21M
-123.12%-332K
79.67%-384K
304.03%506K
-289.88%-1.35M
-526.32%-648K
-Change in payables and accrued expense
-1,090.98%-1.32M
-130.51%-1.31M
-492.05%-3.4M
-24.46%2.17M
-392.87%-3.11M
-89.15%133K
570.38%4.28M
-46.98%868K
0.67%2.87M
-130.37%-631K
Cash from discontinued investing activities
Operating cash flow
-12.30%-17.84M
46.56%-8.42M
11.66%-12.77M
-50.43%-61.69M
-10.78%-15.6M
-69.03%-15.89M
-36.64%-15.75M
-140.76%-14.46M
-132.90%-41.01M
-188.25%-14.08M
Investing cash flow
Cash flow from continuing investing activities
0
0
0.00%-4K
85.34%-39K
94.23%-6K
83.33%-16K
18.75%-13K
92.00%-4K
96.23%-266K
98.49%-104K
Net PPE purchase and sale
--0
--0
0.00%-4K
85.34%-39K
94.23%-6K
83.33%-16K
18.75%-13K
92.00%-4K
-11.76%-266K
-16.85%-104K
Net business purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
0.00%-4K
85.34%-39K
94.23%-6K
83.33%-16K
18.75%-13K
92.00%-4K
96.23%-266K
98.49%-104K
Financing cash flow
Cash flow from continuing financing activities
-500.56%-20M
-98.53%452K
119,133.33%21.43M
-66.32%35.96M
293K
-92.48%4.99M
-15.93%30.69M
-100.46%-18K
270.20%106.78M
0
Net issuance payments of debt
----
----
----
664.62%29.87M
--13K
---44K
----
----
--3.91M
--0
Net common stock issuance
--0
-43.14%452K
119,222.22%21.44M
-90.85%6.09M
--280K
-92.41%5.04M
297.50%795K
-400.00%-18K
7,910.35%66.57M
--0
Net preferred stock issuance
----
----
----
--0
----
----
----
----
29.61%36.31M
--0
Net other financing activities
----
--0
---16K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-500.56%-20M
-98.53%452K
119,133.33%21.43M
-66.32%35.96M
--293K
-92.48%4.99M
-15.93%30.69M
-100.46%-18K
270.20%106.78M
--0
Net cash flow
Beginning cash position
-34.21%49.39M
-4.72%57.35M
-34.75%48.71M
711.39%74.65M
-27.74%64.16M
135.32%75.07M
765.85%60.19M
711.39%74.65M
84.11%9.2M
325.28%88.78M
Current changes in cash
-246.81%-37.84M
-153.35%-7.97M
159.77%8.65M
-139.35%-25.77M
-7.95%-15.31M
-119.19%-10.91M
-40.20%14.93M
-575.86%-14.48M
1,468.86%65.5M
-20.84%-14.19M
Effect of exchange rate changes
--1K
105.45%3K
-143.48%-10K
-225.00%-169K
-368.63%-137K
--0
-266.67%-55K
121.70%23K
-285.71%-52K
82.14%51K
End cash Position
-82.00%11.55M
-34.21%49.39M
-4.72%57.35M
-34.75%48.71M
-34.75%48.71M
-27.74%64.16M
135.32%75.07M
765.85%60.19M
711.39%74.65M
711.39%74.65M
Free cash flow
-12.19%-17.84M
46.60%-8.42M
11.66%-12.77M
-49.52%-61.73M
-10.01%-15.61M
-67.49%-15.91M
-36.46%-15.76M
-138.83%-14.46M
-131.33%-41.29M
-185.18%-14.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2019(Q2)Jun 30, 2019(Q1)Mar 31, 2019(FY)Dec 31, 2018(Q4)Dec 31, 2018(Q3)Sep 30, 2018(Q2)Jun 30, 2018(Q1)Mar 31, 2018(FY)Dec 31, 2017(Q4)Dec 31, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -12.30%-17.84M46.56%-8.42M11.66%-12.77M-50.43%-61.69M-10.78%-15.6M-69.03%-15.89M-36.64%-15.75M-140.76%-14.46M-132.90%-41.01M-188.25%-14.08M
Net income from continuing operations 76.36%-3.97M59.17%-8.26M4.22%-16.38M-45.36%-73.47M-72.80%-19.34M-2.46%-16.79M-57.39%-20.24M-69.22%-17.1M-138.85%-50.55M-35.00%-11.19M
Operating gains losses --21K--1K--1K-40.00%3K--0--------------5K--0
Depreciation and amortization -7.69%36K-5.13%37K0.00%39K30.83%157K0.00%40K44.44%39K44.44%39K50.00%39K79.10%120K73.91%40K
Other non cash items -7,627.48%-33.46M134.47%151K1,411.08%5.05M-35.01%3.75M258.30%4.29M-112.17%-433K-118.47%-438K-86.93%334K916.73%5.78M-401.45%-2.71M
Change In working capital -4,060.30%-8.28M-131.16%-1.21M-319.80%-3.02M108.09%3.17M-48.79%-1.9M-107.48%-199K411.19%3.89M-1.08%1.37M-39.28%1.52M-154.54%-1.28M
-Change in prepaid assets -1,996.69%-6.96M123.96%92K-24.31%383K173.91%997K286.27%1.21M-123.12%-332K79.67%-384K304.03%506K-289.88%-1.35M-526.32%-648K
-Change in payables and accrued expense -1,090.98%-1.32M-130.51%-1.31M-492.05%-3.4M-24.46%2.17M-392.87%-3.11M-89.15%133K570.38%4.28M-46.98%868K0.67%2.87M-130.37%-631K
Cash from discontinued investing activities
Operating cash flow -12.30%-17.84M46.56%-8.42M11.66%-12.77M-50.43%-61.69M-10.78%-15.6M-69.03%-15.89M-36.64%-15.75M-140.76%-14.46M-132.90%-41.01M-188.25%-14.08M
Investing cash flow
Cash flow from continuing investing activities 000.00%-4K85.34%-39K94.23%-6K83.33%-16K18.75%-13K92.00%-4K96.23%-266K98.49%-104K
Net PPE purchase and sale --0--00.00%-4K85.34%-39K94.23%-6K83.33%-16K18.75%-13K92.00%-4K-11.76%-266K-16.85%-104K
Net business purchase and sale --------------0------------------0----
Cash from discontinued investing activities
Investing cash flow --0--00.00%-4K85.34%-39K94.23%-6K83.33%-16K18.75%-13K92.00%-4K96.23%-266K98.49%-104K
Financing cash flow
Cash flow from continuing financing activities -500.56%-20M-98.53%452K119,133.33%21.43M-66.32%35.96M293K-92.48%4.99M-15.93%30.69M-100.46%-18K270.20%106.78M0
Net issuance payments of debt ------------664.62%29.87M--13K---44K----------3.91M--0
Net common stock issuance --0-43.14%452K119,222.22%21.44M-90.85%6.09M--280K-92.41%5.04M297.50%795K-400.00%-18K7,910.35%66.57M--0
Net preferred stock issuance --------------0----------------29.61%36.31M--0
Net other financing activities ------0---16K----------------------------
Cash from discontinued financing activities
Financing cash flow -500.56%-20M-98.53%452K119,133.33%21.43M-66.32%35.96M--293K-92.48%4.99M-15.93%30.69M-100.46%-18K270.20%106.78M--0
Net cash flow
Beginning cash position -34.21%49.39M-4.72%57.35M-34.75%48.71M711.39%74.65M-27.74%64.16M135.32%75.07M765.85%60.19M711.39%74.65M84.11%9.2M325.28%88.78M
Current changes in cash -246.81%-37.84M-153.35%-7.97M159.77%8.65M-139.35%-25.77M-7.95%-15.31M-119.19%-10.91M-40.20%14.93M-575.86%-14.48M1,468.86%65.5M-20.84%-14.19M
Effect of exchange rate changes --1K105.45%3K-143.48%-10K-225.00%-169K-368.63%-137K--0-266.67%-55K121.70%23K-285.71%-52K82.14%51K
End cash Position -82.00%11.55M-34.21%49.39M-4.72%57.35M-34.75%48.71M-34.75%48.71M-27.74%64.16M135.32%75.07M765.85%60.19M711.39%74.65M711.39%74.65M
Free cash flow -12.19%-17.84M46.60%-8.42M11.66%-12.77M-49.52%-61.73M-10.01%-15.61M-67.49%-15.91M-36.46%-15.76M-138.83%-14.46M-131.33%-41.29M-185.18%-14.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data